Join Our Mailing List:
 
Follow Us:
Shop Contact Us
You have 0  Item in Cart | View Cart
310-841-2600
Featured Events
View All Events
Jane Yanagawa, M.D.
Research performed at: UCLA's Jonsson Comprehensive Cancer Center
Specialty/Research Area: Lung Cancer
Award Year: 2018
Career Summary: Dr. Yanagawa graduated from Columbia University in 1999 and then obtained her medical degree at Baylor College of Medicine in 2004. After this, she entered a general surgery residency program at the University of California, San Diego. During her residency training, she devoted an additional two years as a full-time post-doctoral research fellow at the UCLA Lung Cancer Research Program/JCCC, mentored by Dr. Steven Dubinett. She was awarded the thoracic Surgery Foundation/LUNGevity Foundation research grant for her work investigating the role of the epithelial-to-mesenchymal transition in CXCR2 ligand-dependent malignant progression in non-small cell lung cancer. After her general surgery residency, she garnered a highly prestigious fellowship position in thoracic surgery at Memorial Sloan-Kettering Cancer Center to focus on the surgical management of thoracic oncology. Upon graduation, she joined the UCLA faculty as an Assistant Professor-in-Residence in August 2013. 

Year STOP CANCER Award was received:  2018 I.C.O.N./Natasha Girard Seed Grant
 
Description of research performed: Dr. Yanagawa has developed a thriving clinical practice in thoracic surgical oncology. She is also a primary investigator with a laboratory on campus, focusing on translational lung cancer research. Her ultimate goal as a physician-scientist is to improve long-term outcomes in patients with early-stage resectable non-small cell lung cancer. Her research revolves around understanding the role of premalignant lung lesions in the immune-suppressive tumor microenvironment. Ultimately, an enriched understanding of lung carcinogenesis will contribute to the discovery of specific targeted chemoprevention and the development of post-operative strategies to prevent secondary lung cancers.

STOP CANCER is committed to funding the most promising and innovative scientists in their early research of all forms of cancer prevention, treatment, cures and subsequent clinical applications. STOP CANCER works primarily with local National Cancer Institute-designated Comprehensive Cancer Centers and other qualified institutions in the United States to carry out its mission.

Copyright © 2018 STOP CANCER. All Rights Reserved. | Privacy Policy